A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair



Status:Active, not recruiting
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - Any
Updated:2/1/2019
Start Date:April 2016
End Date:September 2019

Use our guide to learn which trials are right for you!

A Prospective, Multi-center Trial of a Long-term Bio-Absorbable Mesh With Sepra Technology in Challenging Laparoscopic Ventral or Incisional Hernia Repair

The objective of this study is to collect additional data on safety, performance and
effectiveness of Phasix™ ST in subjects receiving laparoscopic ventral or incisional hernia
repair at high risk for surgical site occurrence (SSO).

Subjects at high risk are defined as having 1 or more of the following co-morbid conditions:
body mass index (BMI) between 30-40 kg/m2, inclusive, active smokers, chronic obstructive
pulmonary disease (COPD), diabetes, immunosuppression, coronary artery disease, chronic
corticosteroid use, low pre-operative serum albumin, advanced age, or renal insufficiency.

Inclusion Criteria:

- Subject must be 18 years of age or older

- Subject must be willing to give written informed consent

- Subject must be diagnosed with ventral or abdominal incisional hernia

- Subject must be willing to undergo laparoscopic hernia repair using intraabdominal
placement (with or without Component Separation Technique (CST))

- Surgeon must be able to fully close the hernia defect. Defect closure is defined as
complete reapproximation of fascial edges, leaving no gap. Since the safety and
effectiveness of Phasix™ ST Mesh in bridging repairs has not been evaluated or
established, the defect should be closed prior to mesh use.

- Subject is expected to meet the criteria for a Class I wound

- Subjects must have 1 or more of the following pre-study conditions:

1. Body Mass Index (BMI) between 30-40 kg/m2, inclusive

2. Active smoker (including if attempts to quit smoking within two weeks of surgery
have failed and the patient is still an active smoker at the time of surgery)

3. COPD presence on patient self-report

4. Diabetes mellitus (if yes, diagnosis to be confirmed via medical records or
laboratory results according to 2014 Joslin Clinical Guideline for Adults with
Diabetes)(Appendix 5)

5. Immunosuppression

6. Coronary Artery Disease

7. Chronic corticosteroid use: greater than 6 months systemic use

8. Serum albumin less than 3.4 g/dL

9. Advanced age: 75 years or older

10. Renal insufficiency, defined as serum creatinine concentration ≥2.5 mg/dL

Exclusion Criteria:

- Subject has had 4 or more previous hernia repairs (of the index hernia)

- Subject's hernia is > 350 cm2

- Complete removal of existing mesh from a prior hernia repair (in the same affected
area) is not possible

- Subject has intact permanent mesh adjacent to the current hernia to be repaired

- Preperitoneal placement of mesh

- The subject is known to have a collagen disorder

- The subject has peritonitis

- The subject is on or suspected to be placed on chemotherapy medications during any
part of the study

- The subject's Body Mass Index (BMI) is > 40 kg/m2

- The subject has cirrhosis of the liver and/or ascites

- Subject is American Society of Anesthesiology Class 4 or 5

- Subject has a life expectancy of less than 2 years at the time of enrollment

- Subject has any condition that, in the opinion of the Investigator, would preclude the
use of the study device, or preclude the subject from completing the follow-up
requirements

- Subject has a surgical wound classified as Class II (Clean-Contaminated), Class III
(Contaminated) or Class IV (Dirty-Contaminated) as defined by the CDC

- Subject has an active or latent systemic infection

- Patient has a contraindication to placement of mesh

- Subject requires surgical bridge repair as the sole repair

- Subject is pregnant or has plans to become pregnant during the study period

- Subject has enrolled in another interventional clinical study within the last 30 days

- Subject is part of the site personnel directly involved with this study

- Subject has a known allergy to the test device or component materials (patients with
known allergies to tetracycline hydrochloride or kanamycin sulfate should be avoided).
We found this trial at
16
sites
Celebration, Florida 34747
Principal Investigator: Eduardo Parra Davila, MD
Phone: 407-303-4235
?
mi
from
Celebration, FL
Click here to add this to my saved trials
201 Dowman Dr
Atlanta, Georgia 30303
(404) 727-6123
Principal Investigator: Scott Davis, MD
Phone: 404-778-7850
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
740 South Limestone Street
Lexington, Kentucky 40536
Principal Investigator: J. Scott Roth, MD
Phone: 859-218-5151
?
mi
from
Lexington, KY
Click here to add this to my saved trials
Baton Rouge, Louisiana
Principal Investigator: Karl LeBlanc, MD
Phone: 225-765-6547
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Bellevue, Washington 98004
Principal Investigator: Adel El-Ghazzawy, MD
Phone: 425-635-6082
?
mi
from
Bellevue, WA
Click here to add this to my saved trials
1140 Lexington Road
Georgetown, Kentucky 40324
Principal Investigator: Eric Smith, MD
Phone: 502-868-1266
?
mi
from
Georgetown, KY
Click here to add this to my saved trials
500 University Drive
Hershey, Pennsylvania 17033
Principal Investigator: Eric Pauli, MD
Phone: 717-531-6010
?
mi
from
Hershey, PA
Click here to add this to my saved trials
Madison, Wisconsin 53792
(608) 263-2400
Principal Investigator: Jacob Greenberg, MD
Phone: 608-262-1551
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
?
mi
from
Madison, WI
Click here to add this to my saved trials
New Haven, Connecticut 06504
Principal Investigator: Kurt Roberts, MD
Phone: 203-785-4855
?
mi
from
New Haven, CT
Click here to add this to my saved trials
8303 Dodge Street
Omaha, Nebraska 68114
Principal Investigator: Brad Winterstein, MD
Phone: 402-934-0044
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Portland, Oregon 97227
Principal Investigator: Daniel Tseng, MD
Phone: 503-413-7437
?
mi
from
Portland, OR
Click here to add this to my saved trials
Roanoke, Virginia
Principal Investigator: Curtis Bower, MD
Phone: 540-853-0460
?
mi
from
Roanoke, VA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Jeffrey Blatnik, MD
Phone: 314-362-8539
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
4700 Waters Ave
Savannah, Georgia 31404
(912) 350-8000
Principal Investigator: Christopher Senkowski, MD
Phone: 912-350-9032
Memorial Health University Medical Center Memorial University Medical Center (MUMC) is a nonprofit, 622-bed tertiary...
?
mi
from
Savannah, GA
Click here to add this to my saved trials
Wichita, Kansas 67721
Principal Investigator: Noel Sanchez, MD
Phone: 316-268-6009
?
mi
from
Wichita, KS
Click here to add this to my saved trials
Wilmington, North Carolina 28401
Principal Investigator: William Hope, MD
Phone: 910-667-9281
?
mi
from
Wilmington, NC
Click here to add this to my saved trials